Using the Lima cancer registry's 2004 to 2005 cases linked to the national identity register, the authors found that one minus the mortality-incidence ratio closely tracked observed five-year survival for ten common cancers in Lima.
Published as "The mortality-incidence ratio as an indicator of five-year cancer survival in metropolitan Lima". The authors took new cases and deaths for breast, stomach, prostate, thyroid, lung, colon, cervical and liver cancer, non-Hodgkin lymphoma and leukaemia from the Registro de Cáncer de Lima Metropolitana for 2004 to 2005, checked each case's vital status at five years in the national identity and civil status register (RENIEC), and compared observed five-year survival with the complement of the mortality-incidence ratio.
The authors conclude that one minus the mortality-incidence ratio is an appropriate way to approximate five-year survival for these ten cancers in Lima. The registry's 2013 to 2015 report tabulates that figure for each cancer.
Shares Registro de Cáncer de Lima Metropolitana (Metropolitan Lima Cancer Registry), Instituto Nacional de Enfermedades Neoplásicas, Gastric & gastro-oesophageal junction cancer, Cervical cancer.
Shares Registro de Cáncer de Lima Metropolitana (Metropolitan Lima Cancer Registry), Instituto Nacional de Enfermedades Neoplásicas, Cervical cancer, Breast cancer (all types).
Shares Instituto Nacional de Enfermedades Neoplásicas, Gastric & gastro-oesophageal junction cancer, Cervical cancer, Breast cancer (all types).
Shares Instituto Nacional de Enfermedades Neoplásicas, Gastric & gastro-oesophageal junction cancer.
Shares Registro de Cáncer de Lima Metropolitana (Metropolitan Lima Cancer Registry), Instituto Nacional de Enfermedades Neoplásicas, Gastric & gastro-oesophageal junction cancer, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/